Bruker Guides to $2.10-$2.15 EPS as Orders Lag
Instrument suppliers should expect semiconductor orders to convert to revenue slowly, into fiscal 2027 and 2028.
Updated on Nov. 6, 2026 in Corporate Finance
Bruker set its fiscal 2026 non-GAAP EPS outlook at $2.10 to $2.15, with reported revenue forecast at $3.52 billion to $3.56 billion. For companies that buy or sell scientific instruments, the guidance reflects order strength from China, U.S. academic and government buyers, and semiconductor metrology.
Why it matters
Bruker expects fourth-quarter margin improvement from cost savings, favorable mix, earlier orders from China's academic and government markets, and some delayed semiconductor orders. Its booking momentum, with a book-to-bill ratio above one for five consecutive quarters, shows where demand for lab and metrology equipment is currently concentrated.
Bruker guides to non-GAAP EPS of $2.10 to $2.15 and reported revenue of $3.52 billion to $3.56 billion for fiscal 2026, with 1% to 2% organic growth. Bruker Scientific Instruments has posted a book-to-bill ratio above one for five consecutive quarters.
The players
Bruker Corporation
Bruker is a scientific instruments maker whose analytical and life-science equipment serves academic, government, pharmaceutical, and semiconductor customers.
The details
Bruker's margin outlook depends on cost savings and a more favorable product mix, which management expects to lift fourth-quarter operating margin by 250 to 300 basis points over the year. Earlier orders from China's academic and government markets help support revenue timing, while some semiconductor orders that slipped are now expected to convert in fiscal 2027 and, for a portion, fiscal 2028. Shipment timing continues to affect instrument revenue, so reported results can move even when bookings stay strong.
Timeline
Fiscal 2026: Bruker's non-GAAP EPS outlook of $2.10 to $2.15 applies.
Fourth quarter of fiscal 2026: management expects margin improvement.
Fiscal 2027: most semiconductor orders are expected to convert.
Fiscal 2028: some semiconductor orders are expected to convert.
Market Landscape
Bruker's bookings run, with a book-to-bill ratio above one for five consecutive quarters at Bruker Scientific Instruments, is setting up revenue growth that lags orders. Its fiscal 2026 outlook of 1% to 2% organic growth reflects that timing gap rather than a broad acceleration in the instruments market.
Operators in instrument supply chains should plan around delayed shipment timing, since bookings can run ahead of recognized revenue. Businesses selling into semiconductor metrology should expect order conversion to stretch into fiscal 2027 and 2028.
The takeaway
Watch whether Bruker's fourth-quarter margin improvement materializes as guided, since cost savings and mix drive it. Track the pace of semiconductor order conversion across fiscal 2027 and 2028 as the clearest signal of metrology demand.
Further reading
For more on how companies set and revise earnings guidance, see Corporate Finance.
Source note: This article includes information reported by TokenPost.
